Researchers estimate that scarring from MASH (fibrosis) progresses 1 stage every 7 years, on average, but there are ways a person can stop further damage happening to their liver or even reverse the disease
Unfortunately, there are people that are using it in that way, but lets look at the bigger issue, which is changing lives, changing health status, changing health risk, decreasing the risk of heart attack and stroke, admission for heart failure, kidney numbers
In contrast to other AOMs, which either suppress appetite or inhibit fat absorption [23], GLP-1RAs reduce body weight in a number of ways, decreasing appetite and hunger, and increasing satiety, resulting in reduced energy intake [24,25,26]
Your genetic variants in GLP-1 receptor sensitivity (GLP1R rs6923761) and glucose-dependent insulinotropic peptide receptors (GIPR rs1800437) influence how efficiently your cells respond to the medication and how quickly your body processes it
